Mesenchymal stem cells – a new therapeutic option for rheumatic diseases?
More details
Hide details
Submission date: 2014-12-31
Acceptance date: 2015-01-19
Online publication date: 2015-04-10
Publication date: 2015-02-27
Reumatologia 2015;53(1):1-2
Our body is equipped with mesenchymal stem cells (MSCs) possessing unique regenerative and immunoregulatory properties. These cells can be easily isolated from different tissues and safely transplanted. MSCs-based therapy is beneficial in some pathological conditions. However, before expanding clinical application of MSCs to systemic RD several points should be clarified, e.g. it is critical to understand more deeply physiological function of MSCs, standardization of MSCs culture and expansion in vitro is required, the contribution of MSCs to pathology of particular disease and its subtype should be explored, the ideal MSCs source, the optimal dose, frequency and route of MSCs administration should be selected.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Journals System - logo
Scroll to top